Encouraging results in first phase, 11 volunteers given second dose of Covid vaccine at Rohtak PGIMS

Must Read

Former J&K Lt Governor GC Murmu appointed as new CAG

After resigning from the post of Lieutenant Governor of Jammu and Kashmir on Wednesday night, August 5, Girish Chandra Murmu has been appointed as...

Glenmark announces 400 mg ‘FabiFlu’ for Covid-19 treatment

Glenmark Pharmaceuticals, a research-led global pharmaceutical company, on Thursday announced that it is set to introduce a 400 mg version of oral antiviral -...

Karnataka SSLC results 2020 date likely postponed; when to check class 10 results

Indian school children prepare for their Central Board of Secondary Education (CBSE)Raveendran/AFP/Getty Images Karnataka SSLC students have been eagerly waiting for their exam results after...

AAP launches new initiative, calls Karnataka govt’s fight a ‘total disaster’

Coronavirus has made itself an uninvited guest in Karnataka, and so far solutions have been few. Initiatives taken have also been limited. Despite the...

Ravinder Saini

Tribune News Service

Rohtak, August 1

A total of 79 volunteers have so far been successfully administered the first dose of indigenous Covid-19 vaccine, Covaxin, at Pt Bhagwat Dayal Sharma Post Graduate Institute of Medical Science here under the first phase of its human clinical trial. Eleven of the volunteers were given the vaccine of Friday.

The trial aims at ascertaining the vaccine’s efficacy in generating antibodies against coronavirus and any adverse effect on health.

As nothing harmful was witnessed, the doctors have also started giving the second dose–11 were given on Friday–to those who got the first 14 days ago. Prior to that, they underwent a test to check the level of antibodies after the first dose, given on July 17.

“We have got encouraging results after administering the first dose to all 79 volunteers under the first phase. All are being observed closely and none of them has so far complained of any adverse effect on their health. Twenty volunteers were given first dose of the vaccine under part-1 and 59 in part-2 of the first phase,” said Dr Ramesh Verma, co-investigator and Professor at the Community Medicine Department.   

Dr Verma maintained that the Rohtak PGIMS was among 12 institutes across the country and the only one in Haryana selected for the human trials. The nationwide trials would be conducted in two phases–on 375 volunteers in the first phase and 750 in the second.

After vaccination, tests will be conducted on the volunteers to find out the level of antibodies. “The second phase of the trial is likely to start in the first week of September,” he added.

Dr Savita Verma, trial principal investigator and Professor at the PGIMS Department of Pharmacology, said only healthy people in the age group of 18 to 55 years had been included. A written consent had been obtained from the volunteers, she said.

Source link

Popular

Assam’s Dibrugarh University Teacher Arrested For Sharing Porn Video: Police

During interrogation, the accused confessed to the crime. (Representational)Dibrugarh: An assistant professor in Assam's Dibrugarh University was arrested today for allegedly uploading pornographic content...

JK Tyres suspends operations in Mysuru temporarily

JK Tyres and Industries, one of the leading tyre manufacturers in the country, has suspended operations at its facilities in Mysuru after more than...

TDS Rule Amendment : IT Department seeks more disclosure in form

NEW DELHI : After introducing new TDS (tax deducted at source) rates for high-value cash withdrawals from banks, the income tax department has now...

Donald Trump Suspends H-1B, Other Visas Till Year End

Issuing the proclamation, Trump has ignored the mounting opposition to the order (File)Washington: US President Donald Trump has issued a proclamation to suspend issuing...

Lebanon Blasts: Reactions, Support & Condolences across World

See Blast Video - At the End of Post A huge blast in port warehouses near central Beirut storing highly explosive material killed 78 people...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles